W. Michael Korn
@marindoc.bsky.social
Gastrointestinal and molecular oncologist, molecular diagnostics executive, electronic music producer
Reposted by W. Michael Korn
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer | NEJM
Patients with microsatellite-instability–high (MSI-H) or mismatch-repair–deficient (dMMR) metastatic colorectal cancer have poor outcomes with standard chemotherapy with or without targeted therapi...
www.nejm.org
November 28, 2024 at 4:01 AM
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....